Clinical Trial Update: Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial of sorafenib combined with ifosfamide for high-grade soft tissue sarcoma or bone sarcoma resectable by surgery; study terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2011-05-10